Osteoporosis stems from an unbalance between bone mineral resorption and deposition.
Among the numerous cellular players responsible for this unbalance bone marrow (BM) …

… widely used in the treatment of osteoporosis. They have a high affinity … Virtually all patients
with osteoporosis can benefit from them at some … reference drugs in the field of osteoporosis. …

… In humans, clinical BP use has transformed the treatment of post-menopausal osteoporosis,
rare bone diseases such as osteogenesis imperfecta, as well as multiple myeloma and …

… making HO-1 a potential target for osteoporosis treatment. In this Review, we … osteoporosis.
We also examine the potential of HO-1-based pharmacological therapeutics for osteoporosis …

… By offering a range of reversible crosslinking mechanisms, these hydrogels provide
unparalleled versatility and adaptability, opening new horizons in tissue engineering, regenerative …

… Primary osteoporosis is osteoporosis due to aging and/or postmenopausal status. An individual
suspected of having osteoporosis, either due to fragility fracture and/or low BMD by DXA, …

… Osteoporosis is the most common metabolic bone disease. An imbalance in bone turnover
… Postmenopausal osteoporosis is the most common type of osteoporosis, characterized by an …

… An autopsy of a MF case with severe bone pain revealed osteoporosis with microfractures
and periosteal leukaemic infiltration, which may have caused bone pain [4]. A severely …

… There is also a large imbalance in costs for osteoporosis management. One example is the
measurement of serum 25-hydroxyvitamin D, an important test for osteoporosis management …

… in patients with osteoporosis including postmenopausal, male, and secondary osteoporosis.
In … on the management of different forms of osteoporosis and give a review of the respective …